Home › Acute Kidney Injury › Pennsylvania
Acute Kidney Injury clinical trials in Pennsylvania
8 studies for Acute Kidney Injury are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
- St Luke's University Hospital, Bethlehem
- Saint Mary Medical Center, Langhorne
Recruiting
Ages 18 and older · All sexes · Updated Sep 10, 2026 · NCT05758077A Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury.
- Research Site, Philadelphia
- Research Site, Pittsburgh
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07215702Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- University of Pittsburgh, Pittsburgh
- Hillman Cancer Center, Pittsburgh
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Aug 14, 2026 · NCT06699849QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
- Children's Hospital of Philadelphia, Philadelphia
RecruitingObservational study
Up to age 22 · All sexes · Updated May 14, 2026 · NCT06517810POCUS-Guided Diuresis for Decompensated Heart Failure
- UPMC East, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- UPMC Presbyterian, Pittsburgh
- and 2 more
Recruiting
Ages 18 and older · All sexes · Updated Feb 17, 2026 · NCT06921603A Pragmatic Clinical Trial Comparing the Risk of Acute Kidney Injury During Treatment With Vancomycin and Piperacillin-Tazobactam vs. Vancomycin and Cefepime in Hospitalized Patients
- University of Pennsylvania Health System, Philadelphia
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT06954129Remote Ischemic Preconditioning for Renal and Cardiac Protection in Congestive Heart Failure (RICH) Trial
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Dec 15, 2025 · NCT04982419Nafamostat Efficacy in Phase 3 Registrational CRRT Study
- University of Pittsburgh Medical Center, Pittsburgh
Recruiting
Ages 18 to 80 · All sexes · Updated Oct 15, 2025 · NCT06150742From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.